ZeClinics has been granted €1M from the EIC-Pathfinder Challenge for the EdiGenT project t... 14/10/2022 Advanced therapies Corporate Partners - ZeClinics
Innovation Hallmark 'Barcelona Science Park' 14/10/2022 Corporate 2021 was a key year for the consolidation of PCB community companies’ ability to attract private investment and other... Partners - Parc Científic de Barcelona
ÅKRN is now ISO 9001 quality certified 14/10/2022 Corporate AKRN, now part of NAMSA, is now ISO 9001:2015 quality certified by EQA, a recognized Spanish accredited certification... Partners - NAMSA
NORAYBIO celebra su 20 aniversario como empresa de referencia para el sector de las biocie... 17/10/2022 Corporate La empresa, que celebra su aniversario el 21 de octubre, continúa su expansión internacional gracias a la innovación en... Partners - Noray Biosciences Group
Biotech Showcase 2023 Híbrido: 9-11 enero 2023, San Francisco (EEUU) y 18-19 enero 2023, virtual EEUU Del 09/01/2023 07:30 to 19/01/2023 17:00 Healthcare Access to innovation Corporate
Marc Güell wins the Spanish National Research Award for Young People 2022 10/10/2022 Corporate Dr Marc Güell has received the Ángela Ruiz Robles 2022 National Research Award for Young People, in the field of... Partners - Integra Therapeutics S.L.
Flomics Biotech amongst the best 20 startups to participate in Decelera Menorca Program 06/10/2022 Corporate lomics Biotech was selected and participated last week in the highly competitive Decelera Menorca startup program Partners - Flomics Biotech
Atlas Molecular Pharma (Derio), has received FDA approval to initiate clinical development... 04/10/2022 Corporate Atlas Molecular Pharma (Derio), a company dedicated to the identification and development of novel pharmacological... Partners - Inveready
Fundación Cris y Merck lanzaron la campaña #UrgenciaParaLaCiencia con el objetivo de promo... 04/10/2022 Healthcare Corporate Esta campaña pretendía visibilizar el impacto positivo que tiene la investigación a la hora de mejorar la vida de las... Partners - Merck
Almirall: Lebrikizumab cada cuatro semanas mantiene un aclaramiento duradero de la piel en... 29/09/2022 Healthcare Access to innovation Innovative drugs Corporate Almirall ha anunciado recientemente nuevos resultados completos de los estudios de fase 3 en monoterapia para la... Partners - Almirall
